Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma.

Motaz QadanZhi Ven FongAaron M DelmanAhmed GabrRiad SalemShimul A Shah

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2021)

Y90 radioembolization can be safely used in the HCC population to bridge patients to resection or transplantation, induce future liver remnant growth, and select for less aggressive tumor biology prior to surgery.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
minimally invasive
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
coronary artery bypass
patient reported outcomes
current status
percutaneous coronary intervention
atrial fibrillation
mesenchymal stem cells